Evotec Partners With Haplogen to Develop Drugs for Infectious Diseases
November 15, 2012 01:42 ET
|
Evotec AG
HAMBURG, Germany and VIENNA, Austria, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Haplogen GmbH have signed a collaboration agreement to discover and develop small...
Evotec Reports 8% Revenue Growth and a Positive Operating Result of EUR 2.9 m in the First Nine Months of 2012
November 08, 2012 01:45 ET
|
Evotec AG
HAMBURG, Germany, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the third quarter and first nine months of 2012 ending...
Evotec to Report Results for the First Nine Months of 2012 on 08 November 2012
November 01, 2012 08:43 ET
|
Evotec AG
HAMBURG, Germany, Nov. 1, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) will report its financial results for the first nine months of 2012 on Thursday, 08 November 2012.
The Company...
Evotec Extends Ongoing Collaboration With CHDI Foundation
October 29, 2012 02:43 ET
|
Evotec AG
Collaboration aims to accelerate development of drugs that slow the progression of Huntington's disease (HD)
Evotec eligible to receive up to USD 41 million
HAMBURG, Germany, OXFORD,...
Evotec Receives Milestone in Drug Discovery Collaboration
October 08, 2012 01:47 ET
|
Evotec AG
HAMBURG, Germany, Oct. 8, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has received a pre-clinical milestone from its Drug Discovery Collaboration with Novartis....
Evotec AG: Corporate Update
October 04, 2012 01:43 ET
|
Evotec AG
HAMBURG, Germany, Oct. 4, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Dr. Werner Lanthaler, CEO of Evotec, will temporarily stand down from his role within the...
Evotec and Bayer Enter Into Multi-Target Alliance to Fight Endometriosis
October 01, 2012 05:09 ET
|
Evotec AG
HAMBURG, Germany, Oct. 1, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Evotec and Bayer Pharma AG have entered into a five-year, multi-target collaboration with the...
Evotec and Aspireo Enter Into Strategic Advisory Agreement
September 28, 2012 01:50 ET
|
Evotec AG
Teaming up to partner Aspireo's Somatoprim (DG3173)
HAMBURG, Germany and TEL AVIV, Israel, Sept. 28, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Aspireo Pharmaceuticals...
Evotec Receives Milestone Payment as Part of Its Discovery Alliance With Boehringer Ingelheim
September 26, 2012 01:35 ET
|
Evotec AG
HAMBURG, Germany, Sept. 26, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a...
NIH Awards Major Contract to Evotec to Manage and Operate a Small Molecule Repository
September 19, 2012 01:48 ET
|
Evotec AG
NIH Small Molecule Repository
HAMBURG, Germany, Sept. 19, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Evotec has entered into a multi-year compound...